12 Skin Itching Patterns That Correspond to Liver, Kidney, and Blood Disorders

10. Thrombocythemia Essential Erythromelalgia Itching

Essential thrombocythemia, a myeloproliferative disorder characterized by excessive platelet production, can manifest with a unique form of itching associated with erythromelalgia, a condition involving painful, red, warm extremities that burn and itch intensely. This distinctive syndrome typically affects the hands and feet, presenting as episodes of severe burning pain accompanied by intense itching, erythema, and increased skin temperature that can last from minutes to hours. The underlying mechanism involves abnormal platelet aggregation in small blood vessels, leading to microvascular occlusion, inflammation, and activation of pain and itch receptors in affected tissues. Patients often describe the sensation as feeling like their hands or feet are "on fire" with accompanying intense itching that cannot be relieved through conventional means, often requiring cooling measures such as cold water immersion for symptomatic relief. The condition affects approximately 25-30% of patients with essential thrombocythemia and can be one of the presenting symptoms that leads to diagnosis of the underlying blood disorder. Episodes are frequently triggered by heat exposure, exercise, or prolonged standing, and characteristically improve with cooling and elevation of affected extremities. Laboratory evaluation reveals markedly elevated platelet counts, often exceeding 600,000-800,000 per microliter, along with evidence of abnormal platelet function studies and frequently the presence of JAK2, CALR, or MPL gene mutations that confirm the myeloproliferative nature of the disorder. The itching and burning associated with erythromelalgia can be particularly challenging to treat because conventional antihistamines and topical preparations are generally ineffective against this microvascular-mediated symptom complex. Management approaches include platelet reduction therapy with hydroxyurea or anagrelide, low-dose aspirin to prevent platelet aggregation, and symptomatic treatments such as cooling measures, topical anesthetics, or systemic medications including gabap